Al-Frejat Zyad, Martini Nafiza, Esper Alia, Al-Frejat Diana, Younes Samer, Hanna Majd
Faculty of Medicine, Al Baath University, Homs, Syria.
Faculty of Medicine, Damascus University, Damascus, Syria.
Curr Res Pharmacol Drug Discov. 2024 Aug 23;7:100198. doi: 10.1016/j.crphar.2024.100198. eCollection 2024.
GERD is a very familiar diagnosis among health care providers due to its massive spread, and its symptoms can affect the quality of life for a respectable slice of its patients. Therefore, what can only be described as a logical consequence, a pursuit of a treatment that can both relieve symptoms and have minimal side effects is still ongoing to cover the large demographic affected by GERD. In the following review, analysis will be made of GERD, including possible regulatory activity, of certain drugs to the already discussed pathways involved in GERD patients.
由于胃食管反流病(GERD)广泛传播,它在医疗保健提供者中是一种非常常见的诊断,其症状会影响相当一部分患者的生活质量。因此,一种只能被描述为合乎逻辑的结果是,仍在继续寻求一种既能缓解症状又副作用最小的治疗方法,以覆盖受GERD影响的大量人群。在以下综述中,将对GERD进行分析,包括某些药物对GERD患者已讨论过的相关途径可能产生的调节作用。
Curr Res Pharmacol Drug Discov. 2024-8-23
Aliment Pharmacol Ther. 2002-7
J Assoc Acad Minor Phys. 2000
Dig Dis. 2006
Gastroenterol Res Pract. 2013-6-26
Pharm World Sci. 2005-12
Arq Gastroenterol. 2019-8-13
Clin Gastroenterol Hepatol. 2023-6
Nihon Rinsho. 2004-8
Medicina (Kaunas). 2024-3-21
J Fam Pract. 2023-10
J Pharm Technol. 2023-6
Clin Gastroenterol Hepatol. 2023-6
Neurogastroenterol Motil. 2022-12